tiprankstipranks
Immunic Reports Q3 Earnings and Provides Corporate Update
PremiumMarket NewsImmunic Reports Q3 Earnings and Provides Corporate Update
4M ago
Immunic, Inc. Advances MS Trials Amid Financial Update
Premium
Company Announcements
Immunic, Inc. Advances MS Trials Amid Financial Update
4M ago
Immunic reports Q3 EPS (24c), consensus (22c)
Premium
The Fly
Immunic reports Q3 EPS (24c), consensus (22c)
4M ago
Immunic Stock Set to Rise with Consistent Buy Ratings from Analysts
PremiumMarket NewsImmunic Stock Set to Rise with Consistent Buy Ratings from Analysts
4M ago
Immunic price target raised to $13 from $10 at Brookline
Premium
The Fly
Immunic price target raised to $13 from $10 at Brookline
4M ago
B. Riley Reacts to Immunic’s Update on Clinical Benefits of Vidofludimus Calcium   
Premium
Market NewsSponsored
B. Riley Reacts to Immunic’s Update on Clinical Benefits of Vidofludimus Calcium  
5M ago
Immunic assumed with Outperform from Market Perform at Leerink
PremiumThe FlyImmunic assumed with Outperform from Market Perform at Leerink
6M ago
Immunic enrolls first patient in vidofludimus calcium trial
Premium
The Fly
Immunic enrolls first patient in vidofludimus calcium trial
6M ago
Immunic CEO Says “Right Time” to Buy the Stock is Now – Part 2
Premium
Market NewsSponsored
Immunic CEO Says “Right Time” to Buy the Stock is Now – Part 2
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100